FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418131574> ?p ?o ?g. }

• W2418131574 endingPage "42" @default.
• W2418131574 startingPage "42.1" @default.
• W2418131574 abstract "The etiology of fractures is multifactorial, including factors that increase the risk of bone fragility and the risk of falls. In terms of bone fragility, the final pathway is the degree and balance of bone turnover and the quantity, structural distribution and quality of the remodeled bone. Treating osteoporosis means preventing a first or subsequent fracture in patients who have been identified to be at high risk for fractures. Fracture prevention can be summarized using a 5-step approach (figure). The <i>first</i> step is case finding: which subjects/patients deserve attention for fracture risk evaluation? These include patients with a recent fracture (increasingly evaluated in the context of a Fracture Liaison Service), patients with diseases (e.g. inflammatory rheumatic diseases) or medications (e.g. glucocorticoids) that are known to increase the risk of fractures, and subjects with an accumulation of other risk factors for fracture. The <i>second</i> step is risk evaluation, for which bone densitometry, imaging of the spine and evaluation of the presence of risk factors (as found in the FRAX and Garvan algorithms) are available. Once a patient at high risk for fracture is identified, the <i>third</i> step is differential diagnosis for underlying diseases using medical history, clinical examination and laboratory tests. In the <i>fourth</i> step, medical therapy consists of instructing the patient about life style, fall prevention, ensuring sufficient calcium and vitamin D intake and discussion of the possibilities of medication. The choice of drugs is based on the spectrum of demonstrated fracture prevention (vertebral, non-vertebral and hip fractures), route (oral, SC, IV) and frequency of administration (from daily to yearly two times or once) and safety profile. Anti-resorptive drugs (bisphosphonates, denosumab, SERMs), that decrease high bone turnover, are a major approach for fracture prevention. In patients with severe osteoporosis, or having new fractures despite adequate anti-resorptive drug treatment and in patients with low bone remodeling, such as in glucocorticoid osteoporosis, osteo-anabolic treatment (recombinant human PTH fragment teriparatide) should be considered. The <i>fifth</i> step is follow-up for checking compliance, tolerance and efficiency, and to decide about duration of treatment. Possible new treatment options include odanacatib, a specific inhibitor of cathepsin-K, the main collagenase of the osteoclast, for which the results of a phase III clinical trial are on the way, and anti-sclerostin antibodies that stimulate bone formation and that are studied in phase II-III clinical trials. <h3>Disclosure of Interest</h3> P. Geusens Grant/research support from: Pfizer, Abbott, Lilly, Amgen, MSD, Will, Roche, UCB, BMS, Novartis, Consultant for: Amgen, Speakers bureau: Pfizer, Abbott, Lilly, Amgen, MSD, Will" @default.
• W2418131574 created "2016-06-24" @default.
• W2418131574 creator A5085713229 @default.
• W2418131574 date "2015-06-01" @default.
• W2418131574 modified "2023-09-24" @default.
• W2418131574 title "SP0171 How to Treat/Manage (Hot) Osteoporosis" @default.
• W2418131574 doi "https://doi.org/10.1136/annrheumdis-2015-eular.6711" @default.
• W2418131574 hasPublicationYear "2015" @default.
• W2418131574 type Work @default.
• W2418131574 sameAs 2418131574 @default.
• W2418131574 citedByCount "0" @default.
• W2418131574 crossrefType "journal-article" @default.
• W2418131574 hasAuthorship W2418131574A5085713229 @default.
• W2418131574 hasConcept C124490489 @default.
• W2418131574 hasConcept C126322002 @default.
• W2418131574 hasConcept C137627325 @default.
• W2418131574 hasConcept C151730666 @default.
• W2418131574 hasConcept C170033053 @default.
• W2418131574 hasConcept C177713679 @default.
• W2418131574 hasConcept C1862650 @default.
• W2418131574 hasConcept C2776541429 @default.
• W2418131574 hasConcept C2776886416 @default.
• W2418131574 hasConcept C2777525943 @default.
• W2418131574 hasConcept C2779343474 @default.
• W2418131574 hasConcept C2994343686 @default.
• W2418131574 hasConcept C71924100 @default.
• W2418131574 hasConcept C86803240 @default.
• W2418131574 hasConceptScore W2418131574C124490489 @default.
• W2418131574 hasConceptScore W2418131574C126322002 @default.
• W2418131574 hasConceptScore W2418131574C137627325 @default.
• W2418131574 hasConceptScore W2418131574C151730666 @default.
• W2418131574 hasConceptScore W2418131574C170033053 @default.
• W2418131574 hasConceptScore W2418131574C177713679 @default.
• W2418131574 hasConceptScore W2418131574C1862650 @default.
• W2418131574 hasConceptScore W2418131574C2776541429 @default.
• W2418131574 hasConceptScore W2418131574C2776886416 @default.
• W2418131574 hasConceptScore W2418131574C2777525943 @default.
• W2418131574 hasConceptScore W2418131574C2779343474 @default.
• W2418131574 hasConceptScore W2418131574C2994343686 @default.
• W2418131574 hasConceptScore W2418131574C71924100 @default.
• W2418131574 hasConceptScore W2418131574C86803240 @default.
• W2418131574 hasIssue "Suppl 2" @default.
• W2418131574 hasLocation W24181315741 @default.
• W2418131574 hasOpenAccess W2418131574 @default.
• W2418131574 hasPrimaryLocation W24181315741 @default.
• W2418131574 hasRelatedWork W1125957263 @default.
• W2418131574 hasRelatedWork W1948385379 @default.
• W2418131574 hasRelatedWork W1980295295 @default.
• W2418131574 hasRelatedWork W2026132755 @default.
• W2418131574 hasRelatedWork W2028423551 @default.
• W2418131574 hasRelatedWork W2031407875 @default.
• W2418131574 hasRelatedWork W2407712801 @default.
• W2418131574 hasRelatedWork W2411764631 @default.
• W2418131574 hasRelatedWork W4319787241 @default.
• W2418131574 hasRelatedWork W4324135873 @default.
• W2418131574 hasVolume "74" @default.
• W2418131574 isParatext "false" @default.
• W2418131574 isRetracted "false" @default.
• W2418131574 magId "2418131574" @default.
• W2418131574 workType "article" @default.